Related Experiment Videos
Severe Hypertension: Evaluation and Treatment
Robert L Gauer1, Adam I Rifaat2, Daniel R Blankinship3
1Department of Internal Medicine at Womack Army Medical Center, Fort Bragg, North Carolina.
Insights
Severe hypertension in US adults is common, often caused by medication nonadherence in outpatients. Inpatient treatment of severe hypertension may increase risks without improving outcomes, necessitating careful evaluation.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Hypertension affects nearly half of US adults, with severe elevations (≥180/110 mm Hg) seen in over 13% of those with existing hypertension.
- Severe hypertension, defined as blood pressure ≥180/110 mm Hg without new or worsening target organ damage, lacks clear outpatient management guidelines.
- Medication nonadherence is the primary cause of severe hypertension in the outpatient setting.
Purpose of the Study:
- To review current understanding and management strategies for severe hypertension.
- To differentiate between outpatient and inpatient management of severe hypertension.
- To highlight risks associated with inpatient treatment and criteria for evaluating secondary hypertension.
Main Methods:
- Review of existing guidelines for chronic hypertension management.
- Analysis of randomized and observational trials on inpatient treatment of severe hypertension.
- Discussion of common causes and recommended approaches for outpatient severe hypertension.
Main Results:
- Outpatient severe hypertension often requires adjusting or reinitiating antihypertensive therapy, with emphasis on out-of-office monitoring and adherence.
- Inpatient treatment of severe hypertension does not improve short-term outcomes and may elevate risks of cardiovascular events, acute kidney injury, and prolonged hospitalization.
- Short-acting or intravenous antihypertensive agents in hospitalized patients are linked to adverse outcomes.
Conclusions:
- Management of severe hypertension requires addressing outpatient nonadherence and carefully considering the risks versus benefits of inpatient interventions.
- Evaluation for secondary hypertension is crucial in specific patient groups, including those with resistant hypertension or early-onset disease.
- Current evidence does not support routine inpatient treatment for severe hypertension without target organ damage.
Abstract:
Hypertension affects approximately 46% to 48% of US adults, with severe blood pressure elevations (180/110-120 mm Hg or higher) observed in more than 13% of individuals with preexisting hypertension. In the absence of new or worsening target organ damage, this is defined as severe hypertension. Although guidelines provide structured approaches to chronic hypertension management, guidelines for management of acute severe hypertension are limited. In the outpatient setting, medication nonadherence is the most common cause of severe hypertension. This typically requires reinitiating or increasing the dosage of antihypertensive therapy. Out-of-office blood pressure monitoring is recommended, and barriers to adherence should be investigated. In hospitalized patients, transient blood pressure elevations are often triggered by secondary factors such as anxiety, hypervolemia, pain, or withdrawal of home medications. Randomized and observational trials have shown that inpatient treatment of severe hypertension does not improve short-term outcomes but increases the risk of cardiovascular events and acute kidney injury and the length of hospitalization. Use of short-acting or intravenous antihypertensive medications is associated with adverse outcomes and is not recommended. Evaluation for secondary hypertension is recommended in cases of resistant hypertension, progressive blood pressure elevation, age of onset younger than 30 years, or evidence of premature target organ damage.
Related Concept Videos
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology